GLP-1 drugs
A class of drugs (e.g. Ozempic, Mounjaro) originally for weight loss that reduce inflammation, including in the brain, via the gut-brain axis.
As defined in 313 | Eric Topol on the Changing Face of Medicine and Aging
Where it comes up · 4
- Dan Wang2 claims
- 313 | Eric Topol on the Changing Face of Medicine and Aging2 claims
- Theodore Schwartz1 claim
- Ezra Klein on the Abundance Agenda | Conversations with Tyler1 claim
Most important claims · 6 of 6Search all claims for “GLP-1 drugs” →
- Changing the brain's chemistry can make people more prone to risky behaviors: certain Parkinson's drugs have made patients become compulsive gamblers, and the same chemical-modification logic applies to addiction, which is why deep brain stimulation is being tried — effectively in animal models — to modify addiction, and why GLP-1 drugs appear to limit addictive behavior.Theodore Schwartz
- GLP-1 drugs could have been developed decades earlier, but regulatory and system-level choke points made it costly and cumbersome to test them, demonstrating how process barriers inhibit innovation.Ezra Klein on the Abundance Agenda | Conversations with Tyler
- GLP-1 drugs like Ozempic and Mounjaro reduce brain inflammation and rewire reward circuits despite barely entering the brain, because they act on the gut and signal via the vagal nerve through the gut-brain axis, with the brain serving as the master regulator of inflammation throughout the body; notably their inflammation reduction occurs before any weight loss.313 | Eric Topol on the Changing Face of Medicine and Aging
- The key to developing Alzheimer's is not merely having amyloid plaque but whether the brain reacts to it with inflammation; therefore inflammation-reducing interventions—the right diet and exercise, and emerging GLP-1 drugs that reduce brain inflammation—offer a path to preventing Alzheimer's rather than treating it with current dangerous, poorly-working drugs.313 | Eric Topol on the Changing Face of Medicine and Aging
- Major medical advances such as statins, mRNA vaccines, better heart surgery, and improved survival rates after heart attacks and strokes reach far more than the top half of Americans, with Medicare covering prescription and GLP-1 drugs, so in terms of real services most people get the advances that matter, whereas in China most people do not.Dan Wang
- US health care is some of the best in the world for the top 1% and even the top half of the population, with concierge doctors and customized care for the top 0.1-0.01%, but for the bottom half it does not look impressive, and the US underperformed Europe and even poorer countries on early-pandemic bureaucratic measures, so the country has 'bioprosperity for the 0.01%' rather than for all.Dan Wang